[url="]Orthofix Medical Inc[/url]. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate at the Canacco
[url="]Orthofix Medical Inc[/url]. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its second quarter 2025 fin
Orthofix Medical Inc. (OFIX) to release Q2 2025 financial results on August 5, 2025. The earnings call is scheduled for 8:30 am Eastern Time, accessible
Analyst Michael Petusky from Barrington has initiated coverage on Orthofix (OFIX), assigning an Outperform rating and a price target of $16. Orthofix, a medical
In a recent development, Orthofix Medical (OFIX) has received an "Outperform" rating from Barrington Research. The well-regarded analyst Michael Petusky has ini
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the global commercial launch of the TrueLokâ„¢ Elevate Transv
Orthofix Medical Inc. (OFIX) has launched TrueLokâ„¢ Elevate Transverse Bone Transport System globally. This innovative system offers a limb preservatio
Orthofix Medical (OFIX), a prominent name in the medical device industry, has recently received an updated analyst rating from JMP Securities. The firm has chos
On June 4, 2025, [Alan Bazaar](https://www.gurufocus.com/insider/28303/alan-bazaar), a Director at Orthofix Medical Inc (OFIX), purchased 2,250 shares of the co
On May 12, 2025, Alan Bazaar, a Director at Orthofix Medical Inc (OFIX), purchased 3,990 shares of the company. Following this transaction, the insider now owns
Pro Forma Net Sales: $189.2 million, representing a 6% year-over-year constant currency growth.US Spinal Succession Growth: 5.4% on a same sales day basis.Bone
May 06, 2025 / 12:30PM GMTOperator Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welco
Orthofix (OFIX) has updated its financial expectations for the fiscal year 2025. The company anticipates net sales will fall between $808 million and $816 milli
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 20
Revenue: Achieved $193.6 million, surpassing the estimated $191.10 million for the quarter.Earnings Per Share (EPS): Reported a loss of $(1.35) per share, sign
\nEngine Capital LP (together with its affiliates, â\u0080\u009cEngineâ\u0080\u009d or â\u0080\u009cweâ\u0080\u009d), which owns approximately one percent of the outstanding common shares of Lyft, Inc.
Orthofix Medical Inc. (OFIX) has reported a significant uptick in revenue for the first quarter of 2025, marking an 18% to 19% increase compared to the same per